Defective Breast Mesh, Acellular Dermal Matrix (ADM), and Bioabsorbable Scaffold Injury Attorneys in Guadalupe County: The Definitive Guide for Patients and Families
For women across Guadalupe County, from the county seat in Seguin to the growing communities of Schertz, Cibolo, and the Guadalupe County portions of New Braunfels, the journey through breast reconstruction or cosmetic surgery is supposed to be one of healing, restoration, and regained confidence. Whether you are a breast cancer survivor recovering at a facility near the I-10 corridor or a patient who underwent an “internal bra” procedure in a private surgical suite, you trusted that the medical devices placed inside your body were thoroughly tested, specifically cleared for their intended use, and proven safe for long-term implantation.
The reality we have uncovered in our practice at The Manginello Law Firm, PLLC (Attorney911) is far more troubling. Many of the products currently being used in breast surgeries—including acellular dermal matrix (ADM), bioabsorbable scaffolds like GalaFLEX, and various surgical meshes—were never actually cleared or approved by the FDA specifically for use in the breast. We are here to help the women and families of Guadalupe County understand the regulatory failures, the scientific risks, and the legal pathways available when these defective devices cause catastrophic injury.
If you are experiencing persistent pain, late-onset swelling, or have been diagnosed with a rare cancer like BIA-ALCL, you are not alone in this fight. Our firm, led by Managing Partner Ralph Manginello and Associate Attorney Lupe Peña, brings twenty-seven years of continuous legal experience and a background in insurance defense to level the playing field against multi-billion-dollar manufacturers like Becton Dickinson and Allergan. We understand the medical infrastructure serving Guadalupe County patients, including the specialty care concentrated at San Antonio’s academic medical centers, and we are ready to protect your rights.
Understanding the Device Categories: Mesh, ADM, and Scaffolds
Patients in Guadalupe County deserve a clear explanation of what exactly was implanted during their procedures. In our work representing injured women, we categorize these products into three primary groups, each with its own set of mechanical and biological risks.
Acellular Dermal Matrix (ADM)
Acellular Dermal Matrix is a biologic material, usually derived from human cadaver skin or porcine (pig) tissue. Manufacturers “process” the tissue to remove all cells while attempting to preserve the collagen framework. In Guadalupe County area hospitals, surgeons often use ADM like AlloDerm or Strattice to create a “hammock” that supports a breast implant or tissue expander. The theory is that your own cells will grow into this framework. However, as we will discuss in the pathology sections, these biologic products often carry endotoxins that can trigger severe, non-infectious inflammation.
Bioabsorbable Scaffolds
Bioabsorbable scaffolds, most notably the GalaFLEX product line manufactured by Galatea Surgical and Becton Dickinson (BD), are synthetic knits made from a polymer called poly-4-hydroxybutyrate (P4HB). These are often marketed as an “internal bra” to reinforce breast tissue during lifts (mastopexy) or reductions. While these products are designed to be absorbed by the body over 12 to 24 months, many Guadalupe County patients have reported that the scaffolds do not dissolve as promised, leading to palpable mesh edges, chronic pain, and permanent scarring.
Synthetic Surgical Mesh
While less common today in primary breast reconstruction, some surgeons have used traditional polypropylene or composite synthetic meshes—the same materials used in hernia repair—off-label in the breast. These permanent synthetics are incredibly prone to erosion and infection in the sensitive tissue of the breast envelope.
The Guadalupe County Patient and the San Antonio Medical Hub
While many Guadalupe County residents receive initial care at local facilities like Guadalupe Regional Medical Center in Seguin, those requiring complex breast reconstruction or management of serious device complications often travel to the medical hub in San Antonio. If your surgery was performed at a major academic center like UT Health San Antonio or through a specialist at the Mays Cancer Center—the region’s NCI-Designated Comprehensive Cancer Center—your procedure may have involved the high-volume use of ADM or P4HB scaffolds.
Because San Antonio is a tertiary referral hub for Guadalupe County, the concentration of these devices in local operating rooms is significant. We recognize that the “Access-and-Travel” reality for Guadalupe County patients makes it harder to manage post-surgical complications. When a woman in Schertz or Seguin notices redness or fluid collections months after her surgery, she is often told it is a “normal” part of healing. Our experience shows that these “normal” symptoms are often the first signs of a defective device failure or a textured-implant malignancy.
The FDA Regulatory Failure: What Guadalupe County Patients Weren’t Told
The most critical fact that most Guadalupe County patients were never told by their surgeons or the device manufacturers is this: No surgical mesh, ADM, or bioabsorbable scaffold has ever been cleared or approved by the FDA specifically for use in breast surgery.
The 510(k) Pathway and Predicate Creep
Manufacturers like Becton Dickinson (Phasix, GalaFLEX) and Allergan (AlloDerm, Strattice) did not secure FDA approval through the rigorous Premarket Approval (PMA) process, which requires human clinical trials. Instead, they utilized the 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807 Subpart E, a device can reach the market by simply being “substantially equivalent” to an earlier “predicate” device.
This has led to a phenomenon called “predicate creep.” For example, the GalaFLEX scaffold used in breast procedures in Guadalupe County was cleared by the FDA based on its equivalence to a surgical suture. A suture and a large macroporous scaffold used to support an entire breast are not clinically equivalent, yet the 510(k) loop allowed this product into the market without breast-specific safety testing.
Verbatim FDA Warnings
In a historic letter to health care providers on November 9, 2023, titled “Labeling Updates for BD Mesh Products,” the FDA explicitly stated: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” For women in Guadalupe County who are now dealing with reconstruction failure, this admission by the regulator is a cornerstone of our legal strategy.
The Full Brand Universe and Manufacturer Roster
We are currently investigating and litigating cases involving a wide range of manufacturers and brands used in the Guadalupe County area. If you recognize any of these names from your implant card or operative reports, your case may be eligible for a claim.
Acellular Dermal Matrix (Biologic) Brands:
- AlloDerm and AlloDerm RTU (Allergan / AbbVie)
- Strattice (Allergan / AbbVie)
- FlexHD and FlexHD Pliable (MTF Biologics)
- AlloMax (C.R. Bard / Becton Dickinson)
- SurgiMend (Integra LifeSciences)
- DermACELL (LifeNet Health)
Bioabsorbable and Resorbable Scaffold Brands:
- GalaFLEX Scaffold (Galatea Surgical / Tepha / Becton Dickinson)
- GalaFLEX 3D and 3DR Scaffolds
- Phasix Mesh (C.R. Bard / Becton Dickinson)
- DuraSorb (Integra LifeSciences)
- TIGR Matrix (Novus Scientific)
Adjacent Implant Products:
- Allergan BIOCELL Textured Implants (Subject of the July 2019 Worldwide Recall)
- Mentor and Sientra Implants (Subject of the March 2019 FDA Warning Letters)
Our firm understands the corporate parent chains behind these products. For example, Becton Dickinson (BD) acquired C.R. Bard, which owned Davol, and later acquired Tepha/Galatea. This complex web of corporate ownership is meant to confuse individual plaintiffs, but our experience in high-profile institutional litigation—such as our lead counsel role in the $10,000,000 Bermudez v. Pi Kappa Phi case—allows us to pierce these corporate veils and hold the true parent companies accountable.
The Complication Spectrum: Identifying Device Harm in Guadalupe County
Complications from these devices rarely happen immediately. For many Guadalupe County women, the injuries emerge months or even years after the initial surgery. We have categorized these injuries into specific patterns that we use to build your legal case.
BIA-ALCL: Breast Implant-Associated Anaplastic Large Cell Lymphoma
This is not a cancer of the breast tissue itself, but a CD30-positive, ALK-negative T-cell lymphoma that develops in the scar tissue capsule surrounding the implant. It is most heavily associated with textured-surface implants like the Allergan BIOCELL lines. If you have noticed a sudden, large fluid collection (seroma) or a mass 7 to 10 years after your surgery, this is a medical emergency requiring immediate biopsy and pathology review for T-cell receptor monoclonality.
BIA-SCC: Breast Implant-Associated Squamous Cell Carcinoma
An even rarer epithelial tumor identified by the FDA in September 2022. Unlike BIA-ALCL, this can appear with both textured and smooth implants. It is highly aggressive, and the latency period can be decades.
Red Breast Syndrome (RBS) and Endotoxin Science
Many Guadalupe County patients who received ADM (like FlexHD or AlloMax) experience a persistent, sterile redness over the breast. This is not a typical skin infection. Research indicates it is caused by bacterial endotoxins (lipopolysaccharides) retained on the ADM during processing. Even though the product is “sterile,” the endotoxin remains biologically active and triggers a massive inflammatory response.
GalaFLEX and P4HB Scaffold Failure
Common complaints we hear from Guadalupe County women concerning GalaFLEX include:
- Mechanical Failure: The scaffold breaks or degrades too early, leading to “bottoming out” or loss of surgical results.
- Persistence: The scaffold fails to resorb, leading to permanent hardness or palpable edges.
- Tissue Erosion: The mesh edges erode through the skin or are visible through thin breast tissue.
Why Guadalupe County Residents Trust The Manginello Law Firm
When you are facing a multi-national medical device manufacturer, you do not need a generalist personal injury lawyer. You need a team with deep substantive command of 21 CFR Part 803 and 21 CFR Part 814. Generalist firms often file complaints that are immediately dismissed under federal preemption rules because they do not understand how to thread a “parallel claim.”
Ralph Manginello’s 27 Years of Experience
Managing Partner Ralph P. Manginello has been licensed by the State Bar of Texas (Bar Card 24007597) since 1998. With nearly three decades of practice, 8.2/10 Avvo rating, and a Martindale-Hubbell Preeminent 5.0 of 5.0 rating, Ralph has seen the evolution of product liability law from both sides of the aisle. Our firm is admitted to the United States District Court for the Southern District of Texas, and we regularly handle high-stakes litigation in the Western District of Texas (the federal venue for Guadalupe County).
The Lupe Peña Advantage: Insurance Defense and Bilingual Access
Associate Attorney Lupe Peña brings a unique advantage to our Guadalupe County clients. Having spent years in insurance defense, Lupe understands the specific “Defense Playbook” manufacturers use to deny your claim. He knows how they use the “Learned Intermediary Doctrine” to blame your surgeon and how they use “Riegel Preemption” to claim their devices are untouchable. More importantly, Lupe is fluently bilingual.
Hablamos español. Guadalupe County has a rich Hispanic heritage, and we believe that no woman should be gated from justice because of a language barrier. Lupe Peña conducts full client consultations in Spanish without the need for interpreters, ensuring that your story is heard exactly as you tell it. If you or a loved one in Guadalupe County is more comfortable speaking Spanish, call us today at 1-888-ATTY-911 for direct communication with an attorney who speaks your language.
Current High-Profile Capability: Bermudez v. Pi Kappa Phi
We are not just a “listing” service for mass torts. We are active trial attorneys. We currently serve as lead counsel in Bermudez v. Pi Kappa Phi Fraternity, Inc., et al., a $10,000,000 institutional-liability lawsuit filed in November 2025. This case, covered extensively by KPRC 2, ABC13, KHOU 11, and KENS 5, demonstrates our firm’s ability to take on powerful organizations and secure results. We apply that same aggressive, large-scale litigation strategy to every breast mesh and scaffold case we handle in Guadalupe County.
The Legal Landscape in Texas: Statutes and Caps
Navigating the legal system in Texas requires specific knowledge of how our state handles defective medical products. For a patient in Guadalupe County, several key laws apply.
Statute of Limitations and the Discovery Rule
In Texas, the statute of limitations for a product liability claim is generally two years from the date of the injury. However, for devices like breast mesh and ADM, the “Discovery Rule” is vital. This rule may pause the clock until the date you discovered—or reasonably should have discovered—the link between your complication and the defective device. Because the FDA only published its major mesh warning in November 2023, many Guadalupe County women who were injured years ago may still have a valid claim today.
The 15-Year Statute of Repose
Texas law includes a 15-year “Statute of Repose” for products. This means that if your device was first sold to the provider more than 15 years ago, your ability to sue the manufacturer may be barred entirely, regardless of when you were injured. This makes it critical to identify your device and lot numbers as soon as possible.
Damage Caps in Texas
Under Texas Civil Practice and Remedies Code Chapter 74, non-economic damages (pain and suffering, emotional distress, disfigurement) in medical-related claims are often capped at $250,000 per defendant. However, economic damages—which include your past and future medical bills, the cost of revision surgeries, and your lost wages—are not capped. We work with medical life-care planners to ensure we capture the full financial toll these defective devices have taken on your life in Guadalupe County.
The Defense Playbook: How They Will Fight Your Claim
When we file a lawsuit for a patient in Seguin or New Braunfels, the manufacturers and their insurance carriers will use a predictable set of defenses. Because our team has experience in defense work, we are already prepared with the counters.
- “Federal Preemption (The Riegel Defense):” Defense counsel will argue that because the FDA cleared the device, you cannot sue under state law. Our Counter: We cite Medtronic v. Lohr (1996) and the Riegel parallel-claim exception. Since these devices reached the market through 510(k) “substantial equivalence” rather than the PMA pathway, they are not shielded by express preemption.
- “The Learned Intermediary Doctrine:” They will say, “We warned the surgeon, not the patient. If the surgeon didn’t tell you the risks, it’s the surgeon’s fault.” Our Counter: We cite Perez v. Wyeth Laboratories and the direct-to-consumer advertising exception. Manufacturers who market these scaffolds as “internal bras” directly to women have a duty to warn the patient directly, especially when they promote off-label uses.
- “Baseline Complications:” They will argue that seromas and infections occur in all surgeries. Our Counter: We use peer-reviewed meta-analyses showing that ADM increases infection risk by a factor of 2.7. We use the FDA’s own 2021 data naming FlexHD and AlloMax as having significantly higher failure rates than their peers.
Frequently Asked Questions for Guadalupe County Patients
1. Is surgical mesh approved for breast surgery?
No. As the FDA stated in November 2023, the safety and effectiveness of surgical mesh in breast procedures has not been determined by the regulator.
2. I had my reconstruction at a San Antonio hospital five years ago. Is it too late to sue?
Not necessarily. If you only recently discovered the link between your pain and the device—perhaps after the 2023 FDA notification—the discovery rule may preserve your claim. Contact us at 1-888-ATTY-911 for a free evaluation of your specific timeline.
3. What if I can’t afford a lawyer?
At The Manginello Law Firm, we work on a contingency fee basis. This means you pay nothing upfront and no hourly fees. We only get paid if we recover compensation for you. We take the financial risk so you can focus on healing in Guadalupe County.
4. How do I find out which brand of mesh was used?
You have a legal right to your medical records. You should request your “Operative Report” and “Implant Log” from the hospital or surgical center. These documents contain the Unique Device Identifier (UDI) stickers with brand name and lot numbers. If you need help securing these, our team can assist.
5. Is this a class action?
Most defective device cases are handled as “Mass Torts” or “Coordinated Proceedings.” This means your case is filed individually, but it may be consolidated into a Multidistrict Litigation (MDL) for efficiency. For example, the Allergan BIOCELL textured-implant cases are currently consolidated in MDL 2921 in New Jersey.
Evidence Preservation and Immediate Next Steps
If you suspect your breast reconstruction or augmentation is failing due to a defective device, the actions you take now will define your legal future.
- Secure the Operative Report: This is the only way to prove which manufacturer is liable.
- Request Pathology Slides: If you have already had a revision or a fluid drainage, the pathology department at your hospital should have the slides. We can have these reviewed by independent experts for BIA-ALCL markers like CD30 positivity.
- Keep Your Explanted Device: If you undergo revision surgery, demand that the discarded mesh or ADM be preserved. Do not let the hospital return it to the manufacturer for “testing.” That device is critical physical evidence.
- Document Everything: Take photographs of redness or skin changes. Keep a journal of your pain levels and how they affect your life in Guadalupe County.
A Message of Support for Guadalupe County Survivors
We know that for many women in Guadalupe County, this is not just a legal case; it is the continuation of a battle that began with a cancer diagnosis or a difficult decision about prophylactic surgery. WhetherあなたはSeguin, Schertz, or Cibolo, we want you to know that your well-being is our primary focus.
Our firm is deeply rooted in the community. Ralph Manginello’s membership in the Pro Bono College of the State Bar of Texas—reflecting at least 75 hours of pro bono service annually—underscores our commitment to serving those in need. We are members of the Pasadena Chamber of Commerce and maintain a 4.9/5.0 star rating across hundreds of reviews on Birdeye.
You do not have to handle the medical bills, the physical pain, and the legal complexity alone. We host the Attorney 911 podcast to educate the public on these exact issues, and we are ready to put our expertise to work for you.
Contact The Manginello Law Firm (Attorney911) Today
Your time to file a claim is limited by the Texas statute of limitations. The sooner we can begin investigating your surgeon’s use of off-label mesh or ADM, the stronger your case will be.
Call us 24/7 at 1-888-ATTY-911 (1-888-288-9911) for a free, confidential consultation.
There is no obligation, and you will speak directly with a team that understands the gravity of what you have experienced. From our offices in Houston, Austin, and Beaumont, we serve the entire Guadalupe County region.
Hablamos español. Llámenos hoy mismo para hablar con Lupe Peña y recibir ayuda en su idioma. Su salud y su justicia son nuestra prioridad.
The Manginello Law Firm, PLLC
Phone: 1-888-ATTY-911
Website: Attorney911.com
Managing Partner: Ralph P. Manginello (Bar Card 24007597)
Associate Attorney: Lupe E. Peña (Bar Card 24084332)
Disclaimer: This content is for educational purposes and does not constitute legal advice. Past results in cases like Bermudez v. Pi Kappa Phi do not guarantee future outcomes. No attorney-client relationship is formed until a written contract is signed.
